Efficiency of using Canephron® N in the treatment of children with secondary hyperoxaluria

Journal Title: Здоров`я дитини - Year 2017, Vol 12, Issue 7

Abstract

Background. The purpose of our work was to study the clinical effectiveness of the application of phytotherapeutic drug Canephron® N for secondary hyperoxaluria in children in combination with diet as compared to the dietary treatment alone. Materials and methods. 46 children aged 6–18 years with secondary hyperoxaluria were examined. Depending on the treatment scheme, patients are divided into groups: the main group (23 children) and the comparison group (23 persons). All children received dietary treatment with the exception of high-oxalic acid foods and sufficient drinking regime. In addition to diet therapy, the patients of the main group were treated with Canephron® N for 3 months. Daily excretion of oxalates, calcium, uric acid, phosphate and calcium/creatinine ratio in the morning urine before treatment and after 3 months of therapy were studied. Results. After 3 months of therapy, there was a decrease in daily excretion of oxalate in urine in both observation groups. The decrease in urinary excretion of oxalate on the background of therapy was more significant in children of the main group than in the comparison group (3.050 ± 0.320 vs. 1.600 ± 0.102, p < 0.001). The incidence of hyperoxaluria on the background of therapy in the main group decreased from 100 to 56.5 % (p < 0.01), in the comparison group it almost did not change (from 100 to 82.6 %, p > 0.05). The incidence of hypercalciuria in both groups did not change. At the same time, the daily excretion of calcium, phosphorus and uric acid in the main group was significantly reduced. In patients of the main group, there was a decrease in the erythrocyturia rate — from 52.2 to 17.4 % (p < 0.01). In patients of the comparison group, this indicator did not change significantly. The level of daily proteinuria before and after the treatment decreased only in children of the main group — from 0.117 g/day to 0.052 g/day (p < 0.02). Conclusions. Using phytotherapeutic drug Canephron® N for three-month therapy of secondary hyperoxaluria in children in combination with dietary treatment is more effective than monotherapy with diet and leads to a 3-time decrease of the oxalate level in urine. Treatment with restriction of high-oxa­lic acid foods gives the result of not more than 1.6 times. The inclusion of phytotherapeutic drug Canephron® N is accompanied by a 3-fold decrease in the erythrocyturia rate and a reduction of daily proteinuria.

Authors and Affiliations

T. P. Borysova

Keywords

Related Articles

Prospective study on the significance of mucosal barrier dysfunction markers in assessing the effectiveness of the new strategy for treating food hypersensitivity in children

Background. Further search for the ways to correct the key links of food hypersensitivity (FH) skin symptoms remains perspective. Aim of the study was to evaluate pathogenetically grounded therapy of the skin FH symptoms...

Сlinical observation of the child with cystic fibrosis

The clinical observation of the child with cystic fibrosis is described in the article. Cystic fibrosis was diagnosed during the neonatal screening. The child received enzyme replacement therapy. Early respiratory disord...

Clinical Case of Heiner Syndrome

The article presents a clinical observation of the child with a rare nosological entity — Heiner syndrome. Syndrome is characterized by a primary lesion of the lungs, in the pathogenesis the leading factor is hypersensit...

Biopsychosocial Model of Gastroduodenal Pathology in Children

From the standpoint of the biopsychosocial model of medicine, the formation of gastroduodenal diseases occurs as a result of interaction of biological, psychoemotional and psychosocial factors. Contribution of each of th...

A 6-Minute Walk Test in Adolescents with the Circulation Organs Diseases

The results of the conventional and pair 6-minute walk tests have been studied in 56 adolescents being investigated. It has been established that the patients with myocardial patho­logy during 6 minutes of the test cover...

Download PDF file
  • EP ID EP249210
  • DOI 10.22141/2224-0551.12.7.2017.116179
  • Views 93
  • Downloads 0

How To Cite

T. P. Borysova (2017). Efficiency of using Canephron® N in the treatment of children with secondary hyperoxaluria. Здоров`я дитини, 12(7), 754-759. https://europub.co.uk/articles/-A-249210